Issue 21, 2000

Synthesis of sugar-modified analogs of bredinin (mizoribine), a clinically useful immunosuppressant, by a novel photochemical imidazole ring-cleavage reaction as the key step1

Abstract

The imidazole nucleoside bredinin (mizoribine) is a clinically useful immunosuppressant. Derivatization of bredinin by the usual nucleoside chemistry is often troublesome due to the unusual zwitterionic structure of the base moiety. We achieve the synthesis of 5′-modified analogs of bredinin via a novel photochemical imidazole ring-cleavage reaction as the key step. When a solution of 2′,3′-O-isopropylidenebredinin 5 in 0.1 M AcOH is irradiated with a high-pressure mercury lamp, an imidazole ring-cleavage reaction occurs to give the 2-aminomalonamide riboside derivative 16 in 71% yield. Appropriate modifications of the 5′-position of 16 and subsequent condensation with (EtO)3CH to reconstruct the imidazole base moiety follow. Using this imidazole ring-cleavage–reconstruction strategy, some biologically important 5′-modified bredinin analogs, i.e., the 5′-phosphate 2, the 5′-deoxy derivative 3, and the 5′-O-aminopropylcarbamate 4 are efficiently synthesized.

Article information

Article type
Paper
Submitted
10 Jul 2000
Accepted
01 Sep 2000
First published
10 Oct 2000

J. Chem. Soc., Perkin Trans. 1, 2000, 3603-3609

Synthesis of sugar-modified analogs of bredinin (mizoribine), a clinically useful immunosuppressant, by a novel photochemical imidazole ring-cleavage reaction as the key step

S. Shuto, K. Haramuishi, M. Fukuoka and A. Matsuda, J. Chem. Soc., Perkin Trans. 1, 2000, 3603 DOI: 10.1039/B005510G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements